Can insurance deny Wegovy if my BMI is 32?

Yes. A payer can deny coverage even when your BMI meets FDA labeling for Wegovy (BMI at or above 30, or at or above 27 with a weight-related comorbidity). Common BMI-related denial reasons include missing provider-measured height and weight, plan criteria that require comorbidity proof in the BMI 30–34 range, unsatisfied step therapy, or a formulary exclusion. Check the reason code on your pharmacy denial or EOB before you resubmit the same prior auth form.

What BMI does my insurance plan require for Wegovy?

Many commercial plans mirror FDA criteria, but employer and PBM policies can add requirements such as higher BMI thresholds, documented comorbidities, or completed lifestyle programs. The exact criteria appear in your plan's pharmacy benefit document or PBM prior authorization guidelines, not on the FDA label alone. Call member services or review your formulary criteria for the semaglutide (Wegovy) line.

How do I prove my BMI for a Wegovy appeal?

Attach a recent visit note with provider-measured height, weight, and calculated BMI. Many PBMs want measurements from within the past 90 days rather than home scale readings. Include ICD-10 code E66.01 when BMI is 30–39.9, plus comorbidity codes such as I10 for hypertension or E11.65 for prediabetes when your plan requires them at BMI 27–32.

What if my BMI dropped below 30 after starting Wegovy and renewal was denied?

Maintenance denials happen when weight loss puts you below plan thresholds. Your appeal should include your prescriber's maintenance rationale, weight trajectory records, and clinical support for continued therapy to prevent regain. Some plans require periodic reauthorization with current measurements even when BMI falls below 30.

Does BMI 32 with hypertension qualify for Wegovy under most plans?

BMI at or above 27 with a weight-related comorbidity meets FDA labeling and many PBM guidelines. Your appeal should document the hypertension diagnosis with ICD-10 I10 or I11.x, recent blood pressure readings, and any related medications. A generic obesity note without comorbidity evidence is weaker in the BMI 27–32 range than at higher BMI levels.

How long do I have to appeal a Wegovy BMI denial?

The deadline is on your denial letter or pharmacy EOB. ERISA employer plans often allow up to 180 days from notice for internal appeal, while ACA marketplace plans commonly use shorter windows such as 60 days. Medicare Part D redetermination follows separate Medicare clocks. Missing the printed deadline can permanently forfeit appeal rights regardless of how strong your BMI documentation is.

Can AppealFlow help me write a Wegovy BMI denial appeal?

Yes. AppealFlow's free GLP-1 appeal generator at /appeals/glp1-denial-appeal-generator drafts a formal letter tied to your denial reason, BMI documentation, and appeal rights language. Edit the draft with your clinical details and export to PDF or Word before uploading to your PBM portal.

Wegovy Denied at BMI 32: Your Appeal Rights

Q: Can I request external review if my BMI appeal is denied internally?

Most non-grandfathered ACA plans must offer external review after internal denial. Healthcare.gov describes external appeals for marketplace coverage. Self-funded ERISA plans follow different escalation rules printed on your adverse decision. External reviewers evaluate whether your documented BMI and comorbidities meet medically accepted standards rather than only internal PBM policy language.

By AppealFlow editorial•11 min read•Published July 2026•Updated September 2026

Flowchart showing Wegovy BMI 32 denial appeal steps: read denial reason, attach provider-measured BMI records, file internal appeal before deadline, request external review

A BMI of 32 meets FDA labeling for Wegovy, but your plan can still deny coverage when documentation is incomplete, step therapy is unsatisfied, or GLP-1 weight-loss drugs are excluded from the formulary. You have the right to a formal internal appeal before the deadline on your pharmacy denial or EOB, with access to the criteria used in the decision. ERISA employer plans, ACA marketplace plans, and Medicare Part D each follow different appeal clocks printed on your notice.

Why Do Insurers Deny Wegovy When BMI Is 32?

Key Takeaway: BMI 32 meets FDA labeling, but your plan may require comorbidity proof, step therapy completion, or in-office measurement within a set window. The denial reason on your letter, not your BMI alone, determines your appeal strategy.

Wegovy is FDA-approved for chronic weight management in adults with BMI at or above 30, or at or above 27 with a weight-related comorbidity. Plans may still require prior authorization and may apply stricter internal criteria than the FDA label. Pull your denial letter and find the specific reason code before you resubmit the same prior auth form.

Denial pattern	What it usually means	First appeal action
Undocumented BMI	Self-reported weight or outdated measurement	Attach in-office height, weight, and calculated BMI from a recent visit
Comorbidity gap	Plan wants weight-related condition proof in the BMI 30–34 range	Add hypertension, prediabetes, OSA, or dyslipidemia records with ICD-10 codes
Step therapy	Required first-line drugs or programs not documented	Submit step therapy log or exception request; see how to bypass step therapy for weight-loss medications
Formulary exclusion	Plan excludes GLP-1 weight-loss drugs	File a formulary exception citing medical necessity; see formulary exception denied guidance

What Are Your Appeal Rights After a BMI Denial?

Key Takeaway: Federal and plan-type rules give you a written internal appeal, access to criteria used in the denial, and external review in many cases. These rights apply regardless of BMI when you file before the deadline on your notice.

Employer-sponsored plans governed by ERISA generally must provide a full and fair review under ERISA claims procedure rules. That includes a reasonable time to appeal, access to documents used in the decision, and a written explanation of the outcome. ACA marketplace plans follow internal and external review requirements described on Healthcare.gov appeal guidance. Medicare Part D uses a separate redetermination and reconsideration process with clocks on your Medicare denial notice.

None of these rights activate from a prior auth resubmission alone. After a formal denial, file a written internal appeal that cites your appeal rights and addresses the reason code. For deadline ranges by plan type, see our guide on ERISA and health insurance appeal deadlines.

How Do You Appeal a Wegovy BMI Denial Step by Step?

Key Takeaway: File before the deadline, attach a complete clinical packet with in-office BMI measurement, and request a written decision. Incomplete documentation at qualifying BMI levels is a common reason first appeals bounce back without review.

Confirm the appeal deadline on your pharmacy denial or EOB and calendar it immediately.
Schedule an in-office weigh-in if your last documented BMI is older than your plan requires.
Request the plan's pharmacy criteria or formulary policy cited in the denial.
Obtain a prescriber letter of medical necessity tied to the denial code, measured BMI, and ICD-10 E66.01.
Gather comorbidity records such as HbA1c, blood pressure logs, lipid panel, or sleep study results.
Write and submit a formal internal appeal through the PBM channel named on your notice.
Save confirmation numbers and follow up if you do not receive a written decision.
Request external review when internal review upholds the denial and your plan allows it.

For a broader Wegovy workflow, see how to appeal a Wegovy insurance denial. For prior auth mechanics, see how to appeal a prior authorization denial.

Weak vs. Strong BMI Appeal Language

Key Takeaway: Reviewers approve BMI appeals when documentation includes objective measurements and ICD-10 codes, not self-reported weight or generic requests.

❌ Weak Statement	✓ Strong Statement
“My BMI is 32 and I need Wegovy. The scale at home says I qualify.”	“Provider-measured BMI 32.4 on [date] (height 5'6", weight 201 lbs). ICD-10 E66.01. Meets FDA Wegovy indication (BMI at or above 30). Attached: office visit note with calculated BMI.”
“I have health problems related to my weight so I should get coverage.”	“BMI 32.1 with documented comorbidities: hypertension (I10, BP 148/94 on [date]), prediabetes (E11.65, HbA1c 6.3%), and OSA (G47.33, AHI 22 on sleep study [date]). Meets plan criteria for BMI at or above 27 with weight-related comorbidity.”
“Please approve Wegovy. My BMI is high enough under FDA rules.”	“I request internal appeal under plan pharmacy appeal rights. Denial code [code] cited insufficient BMI documentation. Attached: in-office measurement (BMI 32.4), prescriber letter of medical necessity, and step therapy records per plan Section [section].”

Draft Your Wegovy BMI Appeal Letter

AppealFlow's GLP-1 generator builds a regulation-informed letter from your denial reason, measured BMI, and comorbidity records. Edit live, then download PDF or Word before you upload to your PBM portal.

GLP-1 denial appeal generator

What Documents Prove BMI and Comorbidities?

Key Takeaway: At BMI 32, comorbidity documentation often strengthens the packet even when FDA labeling does not require it at BMI 30 or above. Include at least one weight-related condition with supporting clinical evidence when your plan criteria ask for it.

In-office BMI measurement within the window your plan requires
Prescriber letter of medical necessity addressing the specific denial code
ICD-10 E66.01 plus comorbidity codes such as I10, E11.65, G47.33, or E78.5
Lab results and specialist notes supporting comorbidity claims
Denial letter or pharmacy EOB with member ID, claim number, and reason code

Many PBMs apply stricter internal thresholds or require comorbidity proof in the BMI 30–34 range. When your plan document is unclear, over-document rather than submit a BMI-only packet.

How Do You Submit a BMI Appeal Through Your PBM?

Key Takeaway: BMI denials route through your Pharmacy Benefit Manager. Submitting only by mail when your plan requires a portal upload is a common reason appeals get marked incomplete or lost.

Platform	Common plans	Appeal path
CoverMyMeds	Multiple PBMs	Prescriber portal with BMI records and appeal letter attachments when allowed
Express Scripts	Cigna and some BCBS plans	Member portal Pharmacy section or fax on denial letter
OptumRx	UnitedHealthcare and some employer plans	OptumRx.com prior authorization appeal workflow
Caremark	Aetna and CVS Health plans	Caremark.com Coverage and Claims appeal path

Ask your prescriber's office to upload the in-office BMI visit note through the same portal used for the original prior auth. If they initiated the PA through CoverMyMeds, the appeal should follow that channel with your formal appeal letter attached.

What If BMI Drops Below 30 on Renewal or Your Plan Excludes GLP-1s?

Key Takeaway: Maintenance renewals, weight loss below threshold, and employer formulary exclusions require different strategies than an initial BMI documentation denial.

Weight loss below BMI 30 on renewal: If you started Wegovy at BMI 32 and dropped below plan thresholds, your appeal should include your prescriber's maintenance rationale, weight trajectory data, and clinical support for continued therapy to prevent regain.

Employer formulary exclusion: When your plan excludes all GLP-1 weight-loss drugs, a BMI appeal alone may not overturn the denial. You need a formulary exception request citing medical necessity and documented failure of covered alternatives.

Measurement mismatch: Some plans evaluate waist circumference or body fat percentage in addition to BMI. If your appeal cites BMI but the plan evaluated other metrics, address each criterion in your resubmission.

What Are Typical Wegovy BMI Appeal Timelines?

Key Takeaway: Standard internal pharmacy appeals often receive a decision within 30 days when the packet is complete. Expedited review may be available when your prescriber certifies that delay poses a serious health risk.

Timelines depend on whether your plan classifies the request as standard or expedited and whether the PBM needs additional records. ACA non-grandfathered plans that deny internal appeals may offer external review under Healthcare.gov external appeals guidance. Self-funded ERISA plans follow different escalation rules printed on your adverse decision.

What Mistakes Delay BMI 32 Wegovy Appeals?

Key Takeaway: The most common failure at qualifying BMI is insufficient documentation, not insufficient weight. Avoid self-reported measurements and generic prescriber notes.

Using home scale weight instead of in-office measurement.
Ignoring comorbidity requirements in the BMI 30–34 range when your plan criteria require them.
Resubmitting the prior auth form instead of filing a formal written appeal.
Missing the deadline printed on your denial letter or EOB.
Stopping after internal denial without requesting external review when your plan allows it.

Frequently Asked Questions

Common questions about Wegovy BMI denials, documentation requirements, appeal deadlines, and external review.

Generate Your Free Wegovy BMI Appeal Letter

AppealFlow drafts formal GLP-1 appeal letters tied to your denial reason, measured BMI, and comorbidity records. Edit the draft, then export PDF or Word before you upload to your PBM portal.

Start GLP-1 appeal letter General Appeal Tool

100% Free
No Signup
PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Wegovy coverage rules, PBM portals, and appeal deadlines vary by plan and contract year. Verify requirements on your denial letter and formulary before filing. For medical emergencies, call 911. See our full disclaimer.